Patents by Inventor Tadakazu Suyama

Tadakazu Suyama has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 4343736
    Abstract: A process for recovering interferon which comprises contacting a solution containing an interferon produced by the induced cells of human origin with a water-insolubilized sulfated polysaccharide to allow the interferon to be adsorbed on the water-insolubilized sulfated polysaccharide and then selectively eluting the interferon with an aqueous solution of an inorganic salt.
    Type: Grant
    Filed: July 6, 1981
    Date of Patent: August 10, 1982
    Assignee: The Green Cross Corporation
    Inventors: Yahiro Uemura, Hirofumi Arimura, Hiroshi Morise, Satoshi Funakoshi, Tadakazu Suyama
  • Patent number: 4340589
    Abstract: An antithrombin preparation, secure and stable for a long period of time, can be obtained by freeze-drying an aqueous solution containing antithrombin-III as main component in the presence of an effective quantity of at least one member selected from the group consisting of proteins, sugars, amino acids, inorganic salts and salts of organic acids as stabilizer.
    Type: Grant
    Filed: February 18, 1981
    Date of Patent: July 20, 1982
    Assignee: The Green Cross Corporation
    Inventors: Yahiro Uemura, Midori Nagatomo, Satoshi Funakoshi, Tadakazu Suyama
  • Patent number: 4340594
    Abstract: A fat emulsion containing a steroid having an anti-inflammatory activity, comprising an effective quantity of a steroid having an anti-inflammatory activity, 5 to 50% (W/V) of soybean oil, a phospholipid in a weight ratio of 1-50 to 100 of said soybean oil, and a proper quantity of water. This fat emulsion exhibits a long-lasting activity in the region of inflammation and is especially useful in the therapeutic or prophylactic treatment of rheumatism, immunological hemolytic anemia, idiopathic thrombocytopenic purpura, and Paget disease, or in conjunction with kidney transplantation.
    Type: Grant
    Filed: May 6, 1981
    Date of Patent: July 20, 1982
    Assignee: The Green Cross Corporation
    Inventors: Yutaka Mizushima, Kazumasa Yokoyama, Kiichiro Nabeta, Noboru Yamada, Tadakazu Suyama
  • Patent number: 4314935
    Abstract: A process for recovering interferon which comprises contacting a solution containing an interferon produced by the induced cells of human origin with a water-insolubilized sulfated polysaccharide to allow the interferon to be adsorbed on the water-insolubilized sulfated polysaccharide and then selectively eluting the interferon with an aqueous solution of an inorganic salt.
    Type: Grant
    Filed: August 6, 1980
    Date of Patent: February 9, 1982
    Assignee: The Green Cross Corporation
    Inventors: Yahiro Uemura, Hirofumi Arimura, Hiroshi Morise, Satoshi Funakoshi, Tadakazu Suyama
  • Patent number: 4313938
    Abstract: Double-stranded RNA synthesized using native human DNA as template is found to be an excellent interferon inducer with low toxicity in spite of homologous native to host cell. It is produced by reacting ATP, GTP, CTP and UTP with one another in the presence of a native human DNA as template by the catalytic action of an active RNA polymerase to form RNA and subjecting the resulting RNA to annealing by heating it at a temperature of 70.degree. to 100.degree. C. and gradually cooling to room temperature or below to form double-stranded regions between their molecules.
    Type: Grant
    Filed: July 18, 1979
    Date of Patent: February 2, 1982
    Assignee: The Green Cross Corporation
    Inventors: Hirofumi Arimura, Masanori Nagai, Takeshi Yamauchi, Tsutomu Kitagawa, Tadakazu Suyama
  • Patent number: 4309437
    Abstract: Novel 5,10,11,11a-tetrahydro-8-methyl-11-sulfo or sulfino-1H-pyrrolo[2,1-c][1,4]-benzodiazepin-2-acrylamides which have antitumor activity and low toxicity are prepared by reacting corresponding 11-reactive compound with a reactive sulfur compound to form 11-sulfino compounds and, if desired, oxidizing the 11-sulfino compounds to obtain 11-sulfo compound.
    Type: Grant
    Filed: March 4, 1980
    Date of Patent: January 5, 1982
    Assignee: The Green Cross Corporation
    Inventors: Yasuo Ueda, Yoshio Kagitani, Eiji Sako, Tadakazu Suyama, Nobuhiko Komatsu, Daisuke Satoh
  • Patent number: 4286063
    Abstract: A method for producing a thrombolytic preparation characterized in that among treatment conditions in the urokinase production pH is maintained within the neutral or weakly alkaline range throughout each treatment step to produce a thrombolytic preparation containing urokinase having a molecular weight of 54,000.+-.10,000 as major ingredient.
    Type: Grant
    Filed: December 19, 1979
    Date of Patent: August 25, 1981
    Assignee: The Green Cross Corporation
    Inventor: Tadakazu Suyama
  • Patent number: 3958014
    Abstract: An injectable fluorocarbon emulsion capable of carrying oxygen, which can be used as artificial blood and organ perfusate, is prepared by emulsifying a fluorocarbon, having an ability to dissolve at least 30 V/V % of oxygen under a 100% oxygen atmosphere at an atmospheric pressure, in an aqueous salt solution with a surfactant, centrifuging the resulting aqueous emulsion thereby to reduce the fluorocarbon particles in the emulsion in size to particle sizes of the order of about 0.05 to 0.25 .mu., and then sterilizing the thus obtained emulsion under rotation. The resulting fluorocarbon emulsion can be used as an emergency blood substitute for transfusion.
    Type: Grant
    Filed: March 20, 1973
    Date of Patent: May 18, 1976
    Assignees: The Green Cross Corporation, Tanabe Seiyaku Co., Ltd.
    Inventors: Ryozo Watanabe, Tadakazu Suyama, Kazumasa Yokoyama, Yohei Odaka